Collagen alpha-1(III) chain
| GO Term | Evidence Code | Reference |
|---|---|---|
| in utero embryonic development | ||
| neuron migration | ||
| tissue homeostasis | ||
| chondrocyte differentiation | ||
| cell-matrix adhesion |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| collagen type III trimer |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protease binding | ||
| integrin binding | ||
| integrin binding | ||
| extracellular matrix structural constituent | ||
| extracellular matrix structural constituent |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 96 |
|
|||
| 146 |
|
|||
| 152 |
|
|||
| 263 |
|
|
||
| 614 |
|
|||
| 623 |
|
|
||
| 646 |
|
|||
| 721 |
|
|||
| 736 |
|
|||
| 764 |
|
|
| Pathway Name | Organism |
|---|---|
| Assembly of collagen fibrils and other multimeric structures | Homo sapiens |
| Collagen biosynthesis and modifying enzymes | Homo sapiens |
| Collagen chain trimerization | Homo sapiens |
| Collagen degradation | Homo sapiens |
| Developmental Lineage of Pancreatic Ductal Cells | Homo sapiens |
| ECM proteoglycans | Homo sapiens |
| Fibronectin matrix formation | Homo sapiens |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | Homo sapiens |
| Integrin cell surface interactions | Homo sapiens |
| MET activates PTK2 signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:13359 | Ehlers-Danlos syndrome | |
| DOID:14756 | vascular type Ehlers-Danlos syndrome | |
| DOID:783 | end stage renal disease | |
| DOID:14757 | Ehlers-Danlos syndrome hypermobility type |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026